Sponsor:
Artiva Biotherapeutics, Inc.
Code:
NCT06265220
Conditions
Lupus Nephritis - WHO Class III
Lupus Nephritis - WHO Class IV
Refractory Systemic Lupus Erythematosus
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
AB-101
Cyclophosphamide
Fludarabine
Rituximab
Obinutuzumab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations